Bad Blood: Secrets and Lies in a Silicon Valley Startup
by John Carreyrou
On This Page
Description
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The show more technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley. show lessTags
Recommendations
Member Reviews
Elizabeth Holmes wanted to be the next Steve Jobs. She wanted to remembered as an entrepreneur who changed the world, with a glowing biography of her insight and toughness by someone like Walter Isaacson. But her company was an immense fraud that is still tumbling down around her, SEC fines filed and real charges pending. This is The Soul of a New Machine as done by Joel and Ethan Coen. Arrogant people, machines that fail constantly, and an intricate web of lies and threats that, finally, implodes spectacularly in the face of reality. Short of the Coen Brothers, Carreyrou is the best man for the job, the Wall Street Journal reporter who broke the story that killed Theranos and turned Holmes into a byword for a meteoric fall from grace. show more Bad Blood is thrilling. I stayed up past 2:00 AM reading it.
Holmes had ambition, I'll give her that. She dropped out of Stanford to chase a dream of a whole new spectrum of blood tests, which would use a few drops of blood milked from a finger to do instant full spectrum lab workup in the comfort of someone's home. No more needles, no more visits to the phlebotomist. Just a sleek, iPhone like-portal to a word of personalized on-demand medical monitoring.
The ambition was grand. There was just one minor problem. The test didn't work, and never did. Microfluidic capillaries jammed, software bugged out, readings swung wildly. As Ludwig Fleck said, "A fact is that which resists arbitrary thinking," and whatever Holmes and her investors thought, as long as the various models of analyzers returned inaccurate, Theranos was nothing but a dream.
That didn't stop Elizabeth Holmes. If she had any real talent, it was bending (mostly older, mostly male) investors to her vision. Theranos moved from one round of venture capital funding to another, becoming the highest valued unicorn in Silicon Valley, despite repeated failures of their basic products. The Theranos board included right-wing ghouls like Henry Kissinger, Rupert Murdoch, and George Schultz, along with General (now Sec. Def.) Mattis, and Darth Vader of the legal profession, David Boies. Holmes also buddied up to Democrats, including Vice President Biden and Candidate Hillary Clinton.
The real action of the book is the insanity inside Theranos. Senior executive Ramesh "Sunny" Balwani, also Holmes' much older boyfriend, must have studied Beria as a leader. Information was tightly controlled to prevent 'leaks'. Skeptics and bearers of bad news were fired. The victims of sudden and summary firings were slapped with massive NDAs and followed by private detectives. Meanwhile, Theranos bodged together a lab out of commercially available equipment, operated in total violation of best practices. The Theranos tests were a far cry from what was advertised, and were wildly inaccurate to boot. The harms were real. One Arizona woman, on receiving a Theranos test with Potassium levels that indicated an immanent stroke, spent Thanksgiving in the ER, paying thousands of dollars out of pocket for totally unnecessary brain scans. The emotional damage is just as real, if harder to quantify. The only thing that limited the negative consequences were the relative small number of roll-out sites in Phoenix.
As a handful of whistleblowers made contact with Carreyrou, and he began investigating. The whole house of cards that was Theranos began to collapse, months after Elizabeth Holmes made her mainstream PR debut and the company's valuation soared to over $9 billion. Reading the failures of management in detail is astounding. Regulatory strategy was to slide between the FDA and the smaller agency that manages lab tests, which is absurd. The basic research was driven by design wish lists: a final box no larger than this, a few drops of blood and no more, rather than an actual research agenda. It must have been terrifying to work for Theranos, realize it was all a fraud, and that you were powerless against Elizabeth Holmes' political and legal connections. Ian Gibbons, a key scientist, committed suicide rather than be deposed as a witness against the company.
In the end, the system worked, sort of. Theranos was shut down, Holmes and Balwani are disgraced and charged with numerous crimes. The company eagerly exploited a gray and under-regulated area to always surf ahead of their promises. They lied and bullied relentlessly. In retrospect, the final crash was never in doubt. But it is astounding that Holmes and Theranos got so far, with little more than intense charisma and a slick sales pitch.
I wonder how many other Silicon Valley unicorns are made of plaster. show less
Holmes had ambition, I'll give her that. She dropped out of Stanford to chase a dream of a whole new spectrum of blood tests, which would use a few drops of blood milked from a finger to do instant full spectrum lab workup in the comfort of someone's home. No more needles, no more visits to the phlebotomist. Just a sleek, iPhone like-portal to a word of personalized on-demand medical monitoring.
The ambition was grand. There was just one minor problem. The test didn't work, and never did. Microfluidic capillaries jammed, software bugged out, readings swung wildly. As Ludwig Fleck said, "A fact is that which resists arbitrary thinking," and whatever Holmes and her investors thought, as long as the various models of analyzers returned inaccurate, Theranos was nothing but a dream.
That didn't stop Elizabeth Holmes. If she had any real talent, it was bending (mostly older, mostly male) investors to her vision. Theranos moved from one round of venture capital funding to another, becoming the highest valued unicorn in Silicon Valley, despite repeated failures of their basic products. The Theranos board included right-wing ghouls like Henry Kissinger, Rupert Murdoch, and George Schultz, along with General (now Sec. Def.) Mattis, and Darth Vader of the legal profession, David Boies. Holmes also buddied up to Democrats, including Vice President Biden and Candidate Hillary Clinton.
The real action of the book is the insanity inside Theranos. Senior executive Ramesh "Sunny" Balwani, also Holmes' much older boyfriend, must have studied Beria as a leader. Information was tightly controlled to prevent 'leaks'. Skeptics and bearers of bad news were fired. The victims of sudden and summary firings were slapped with massive NDAs and followed by private detectives. Meanwhile, Theranos bodged together a lab out of commercially available equipment, operated in total violation of best practices. The Theranos tests were a far cry from what was advertised, and were wildly inaccurate to boot. The harms were real. One Arizona woman, on receiving a Theranos test with Potassium levels that indicated an immanent stroke, spent Thanksgiving in the ER, paying thousands of dollars out of pocket for totally unnecessary brain scans. The emotional damage is just as real, if harder to quantify. The only thing that limited the negative consequences were the relative small number of roll-out sites in Phoenix.
As a handful of whistleblowers made contact with Carreyrou, and he began investigating. The whole house of cards that was Theranos began to collapse, months after Elizabeth Holmes made her mainstream PR debut and the company's valuation soared to over $9 billion. Reading the failures of management in detail is astounding. Regulatory strategy was to slide between the FDA and the smaller agency that manages lab tests, which is absurd. The basic research was driven by design wish lists: a final box no larger than this, a few drops of blood and no more, rather than an actual research agenda. It must have been terrifying to work for Theranos, realize it was all a fraud, and that you were powerless against Elizabeth Holmes' political and legal connections. Ian Gibbons, a key scientist, committed suicide rather than be deposed as a witness against the company.
In the end, the system worked, sort of. Theranos was shut down, Holmes and Balwani are disgraced and charged with numerous crimes. The company eagerly exploited a gray and under-regulated area to always surf ahead of their promises. They lied and bullied relentlessly. In retrospect, the final crash was never in doubt. But it is astounding that Holmes and Theranos got so far, with little more than intense charisma and a slick sales pitch.
I wonder how many other Silicon Valley unicorns are made of plaster. show less
The Theranos story is so fascinating. Carreyrou paces the book evenly, slowly building his case. I borrowed this from a clinical chemist who plays (per him) a bit role in the story, appearing in a couple sentences within the book. When I returned his copy, the two of us sat in his office just marveling at how things progressed so far. Within my own little clinical chemistry domain, CLIA looms like a Greek god -- all-powerful and all-knowing. Should we accidentally make a typo in our data, CLIA will send bolts of lightning to destroy us. The idea that a lab somehow became CLIA-certified with such significant variance in their data even before the straight-out fraud is almost unbelievable.
In addition, this seems like any doctor in their show more right mind would know what to make of Theranos. My best friend who works with silicon valley startups asked me about it several years ago, when I was still in residency, and I told her that the problem with capillary draws was hemolysis (blood cells splitting) and that you could never get some accurate results do that - and that's baked in to the blood draw, before you even get to the machinery. Any doctor worth their salt knows this.
So this is an almost fantastical story about how someone by force of personality alone paraded out technology that everyone knew was impossible, and somehow, without ever really inventing anything became a billionaire running laboratory testing in clinical labs on patients. It's pretty serious and scary stuff.
While reading it, I couldn't help but be amazed by the number of smart, well-educated people who were at least temporarily a party to this, often bullied by fancy lawyers and nondisclosure agreements. I think there's a lot here about how much the assumptions of civil society are really what keep us in check more so than institutions like CLIA or CAP. Once someone starts operating in bad faith, it's pretty scary how far they can get. On the other hand, Theranos was pretty much brought down by Carreyrou assisted by a pair of early-twenty-somethings who felt they had to speak out. So I think there's also a lot here about the importance of protecting whistle-blowers and the media. show less
In addition, this seems like any doctor in their show more right mind would know what to make of Theranos. My best friend who works with silicon valley startups asked me about it several years ago, when I was still in residency, and I told her that the problem with capillary draws was hemolysis (blood cells splitting) and that you could never get some accurate results do that - and that's baked in to the blood draw, before you even get to the machinery. Any doctor worth their salt knows this.
So this is an almost fantastical story about how someone by force of personality alone paraded out technology that everyone knew was impossible, and somehow, without ever really inventing anything became a billionaire running laboratory testing in clinical labs on patients. It's pretty serious and scary stuff.
While reading it, I couldn't help but be amazed by the number of smart, well-educated people who were at least temporarily a party to this, often bullied by fancy lawyers and nondisclosure agreements. I think there's a lot here about how much the assumptions of civil society are really what keep us in check more so than institutions like CLIA or CAP. Once someone starts operating in bad faith, it's pretty scary how far they can get. On the other hand, Theranos was pretty much brought down by Carreyrou assisted by a pair of early-twenty-somethings who felt they had to speak out. So I think there's also a lot here about the importance of protecting whistle-blowers and the media. show less
Having worked at a variety of small pharma and biotech companies (including on that developed clinical diagnostic test kits), there was much in this book that resonated with me. This book should be required reading for anyone who begins work at a start-up. However, in addition to containing many lessons as to how you should NOT run a company and the red flags to look out for when you work at a dysfunctional organization, the book is a great read, even knowing how it ends. There are many fascinating and troubling tales within this book. John Carreyrou deserves much credit for his thorough research, his guts and perseverance, and his masterful storytelling.
This is an incredible story and a gripping book--most legal thriller writers would reject it as unbelievable.
If you had an idea for what you thought medicine would do, how would you go about it? For Elizabeth Holmes, the answer was surprising: drop out of college and found a company for a product that she didn't know how to make, didn't understand the underlying science for, or even know if it could be done. And rather than spend time researching and developing the product, you'd sell it anyway.
The scale of her fraud is breathtaking. She brazenly lied to investors, to scientists, to the government, to the media, and to all of Silicon Valley for over a decade. To protect her secret, she ran Theranos as a tyranny. The human cost of her show more actions to her employees alone is horrific, and we're lucky she harmed fewer patients.
The most intriguing aspect of the book is the way she was able to transform herself into a Silicon Valley myth. She got everyone to believe what they wanted to believe: that she was a visionary, and that they'd be stupid to pass up this amazing technology that she refused to demonstrate for them. Up till the final collapse, some very famous people stuck by her. It's not a pleasant portrait of her investors or the culture. show less
If you had an idea for what you thought medicine would do, how would you go about it? For Elizabeth Holmes, the answer was surprising: drop out of college and found a company for a product that she didn't know how to make, didn't understand the underlying science for, or even know if it could be done. And rather than spend time researching and developing the product, you'd sell it anyway.
The scale of her fraud is breathtaking. She brazenly lied to investors, to scientists, to the government, to the media, and to all of Silicon Valley for over a decade. To protect her secret, she ran Theranos as a tyranny. The human cost of her show more actions to her employees alone is horrific, and we're lucky she harmed fewer patients.
The most intriguing aspect of the book is the way she was able to transform herself into a Silicon Valley myth. She got everyone to believe what they wanted to believe: that she was a visionary, and that they'd be stupid to pass up this amazing technology that she refused to demonstrate for them. Up till the final collapse, some very famous people stuck by her. It's not a pleasant portrait of her investors or the culture. show less
Best for:
Anyone who enjoys a true story about shady people who (for the most part) get what’s coming to them.
In a nutshell:
An experienced Elizabeth Holmes convinces a lot of people that she is on to the next big thing in biotechnology. She isn’t, and she gets VERY touchy when people point that out. Also, lots of powerful old white guys make some absurd financial decisions.
Worth quoting:
N/A
Why I chose it:
I listened to the podcast “The Drop Out,” which is just a few episodes long, but was definitely enough to get me interested.
Review:
Oh MY god did I love this book. I purchased the audio version and planned to listen to it during some long runs I have coming up. Instead, I could barely put it down, and listened to it every chance I show more got. It is a meticulously researched book, and Carreyrou explains complicated things (like how blood tests work) in ways that are not condescending or difficult to understand. The story develops slowly but never drags, as Carreyrou lays out the entire fiasco step by step.
What it comes down to is the Elisabeth Holmes was — is — a fraud. I think she started out with an idea (blood testing without the needles), and then became like a dog with a bone. She couldn’t and wouldn’t accept anyone disagreeing with her, because she was going to change the world. I don’t believe she was motivated by greed or money; I think she was fully motivated by her ego. She couldn’t dare admit that she was in over her head, or that her company Theranos wasn’t able to do what she promised; she just kept lying to others (and possibly herself) in the hopes that everything would work itself out.
The story is at times unbelievable. The number of attorneys involved. The cloak and dagger way the company treated its ‘trade secrets.’ The threatening letters. The lawsuits. The firings of anyone who questions anything. To think that people act this way — and think it is justified — is distressing to say the least. And frankly, I reserve about as much disgust for the attorneys who did Elisabeth Holmes’s bidding as I do for Holmes and her C-suite colleagues. The way the tormented people is offensive.
One area I think could have been developed a little bit more is the exploration of what the failures of the blood testing did to people’s lives. Carreyrou does share some stories of those who were harmed — such as a woman who ended up with $3,000 in unnecessary medical bills — but that can at times get lost in the story. And of course many of the whistle-blowers were motivated by the danger that faulty blood testing can cause, but it still wasn’t necessarily woven in as much as I would have liked. But that’s a very minor quibble, because it’s definitely discussed.
A little more than halfway through the book, the author become part of the story. It’s a slightly dramatic moment, but I think it is handled very well. The investigation of the Wall Street Journal article that predates the book is a huge reason why Theranos has been sued and why some of its leadership have been charged with crimes. It would be impossible for him to stay out of it, and the book would have suffered greatly without his perspective being shared in this way.
There were many moment when I got so angry at the things people were getting away with, but the last couple of chapters — I mean, there are some serious just deserts being served. It’s chef’s kiss come to life.
Keep it / Pass to a Friend / Donate it / Toss it: Keep it. And probably listen again soon. show less
Anyone who enjoys a true story about shady people who (for the most part) get what’s coming to them.
In a nutshell:
An experienced Elizabeth Holmes convinces a lot of people that she is on to the next big thing in biotechnology. She isn’t, and she gets VERY touchy when people point that out. Also, lots of powerful old white guys make some absurd financial decisions.
Worth quoting:
N/A
Why I chose it:
I listened to the podcast “The Drop Out,” which is just a few episodes long, but was definitely enough to get me interested.
Review:
Oh MY god did I love this book. I purchased the audio version and planned to listen to it during some long runs I have coming up. Instead, I could barely put it down, and listened to it every chance I show more got. It is a meticulously researched book, and Carreyrou explains complicated things (like how blood tests work) in ways that are not condescending or difficult to understand. The story develops slowly but never drags, as Carreyrou lays out the entire fiasco step by step.
What it comes down to is the Elisabeth Holmes was — is — a fraud. I think she started out with an idea (blood testing without the needles), and then became like a dog with a bone. She couldn’t and wouldn’t accept anyone disagreeing with her, because she was going to change the world. I don’t believe she was motivated by greed or money; I think she was fully motivated by her ego. She couldn’t dare admit that she was in over her head, or that her company Theranos wasn’t able to do what she promised; she just kept lying to others (and possibly herself) in the hopes that everything would work itself out.
The story is at times unbelievable. The number of attorneys involved. The cloak and dagger way the company treated its ‘trade secrets.’ The threatening letters. The lawsuits. The firings of anyone who questions anything. To think that people act this way — and think it is justified — is distressing to say the least. And frankly, I reserve about as much disgust for the attorneys who did Elisabeth Holmes’s bidding as I do for Holmes and her C-suite colleagues. The way the tormented people is offensive.
One area I think could have been developed a little bit more is the exploration of what the failures of the blood testing did to people’s lives. Carreyrou does share some stories of those who were harmed — such as a woman who ended up with $3,000 in unnecessary medical bills — but that can at times get lost in the story. And of course many of the whistle-blowers were motivated by the danger that faulty blood testing can cause, but it still wasn’t necessarily woven in as much as I would have liked. But that’s a very minor quibble, because it’s definitely discussed.
A little more than halfway through the book, the author become part of the story. It’s a slightly dramatic moment, but I think it is handled very well. The investigation of the Wall Street Journal article that predates the book is a huge reason why Theranos has been sued and why some of its leadership have been charged with crimes. It would be impossible for him to stay out of it, and the book would have suffered greatly without his perspective being shared in this way.
There were many moment when I got so angry at the things people were getting away with, but the last couple of chapters — I mean, there are some serious just deserts being served. It’s chef’s kiss come to life.
Keep it / Pass to a Friend / Donate it / Toss it: Keep it. And probably listen again soon. show less
I tore through this book. The story is fascinating, and I found it generally well written. It astounds me that so many generally smart people fell for this, although I think that says something about how much we all want to believe. It is also remarkable how much self-delusion it must have taken for Holmes to bald faced lie for so long (when it was obvious that if the devices don't work she would eventually be caught). The central idea of the Theranos product would be wonderful - but I think we're still a long way from having that sort of technology.
Straightforward reporting of the Theranos saga. On full display is the greed, ego, chutzpah and arrogance of founder Elizabeth Holmes, all leading to her inevitable (and satisfying) crash and burn. Apparently it was only dumb luck that nobody died from the inaccurate lab tests that incredibly this company was allowed to unleash on an unsuspecting public. The laxity of the regulatory process that allowed this to happen will make your blood boil, pun intended.
Members
- Recently Added By
Published Reviews
ThingScore 75
The author’s description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist; Carreyrou wisely lets the evidence speak for itself. As presented here, Holmes harbored delusions of grandeur but couldn’t cope with the messy realities of bioengineering. Swathed in her own reality distortion field, she dressed in black turtlenecks to emulate show more her idol Jobs and preached that the Theranos device was “the most important thing humanity has ever built.” Employees were discouraged from questioning this cultish orthodoxy by her “ruthlessness” and her “culture of fear.” Secrecy was obsessive. Labs and doors were equipped with fingerprint scanners. show less
added by danielx
Lists
Top Five Books of 2018
802 works; 265 members
Recommend the 20 best books you've read in the last five years
2,168 works; 606 members
Non-Fiction Worth Reading
1,016 works; 262 members
ORCID Book list
27 works; 1 member
Litsy Awards 2018
248 works; 9 members
Books Read in 2019
4,052 works; 110 members
Penguin Random House
458 works; 4 members
Mind Expanding Books by hackerkid
581 works; 8 members
Books We Couldn't Put Down
443 works; 197 members
Author Information

4 Works 3,382 Members
John Carreyrou is an American journalist and author. He was born in New York and raised in Paris. He graduated from Duke University in 1994 with a B.A. in political science and government. He has worked for The Wall Street Journal since 1999. Currently, he is based in New York, but has worked in Brussels and Paris. He has covered a wide number of show more topics. He was part of a team that won a Pulitzer Prize for Explanatory Reporting, for covering corporate scandals. In 2015, he and several colleagues wrote a series of articles on fraud and Medicare, for which they won the Pulitzer Prize for Investigative Reporting. He won the George Polk, Gerald Loeb, and Bartlett & Steele awards for his coverage of the company Theranos. (Bowker Author Biography) show less
Some Editions
Awards and Honors
Awards
Distinctions
Notable Lists
Common Knowledge
- Canonical title*
- 惡血:矽谷獨角獸的醫療騙局!深藏血液裡的祕密、謊言與金錢
- Original title
- Bad Blood
- Original publication date
- 2018
- People/Characters
- Elizabeth Holmes; Shaunak Roy; Ramesh “Sunny” Balwani; Tyler Shultz; Rupert Murdoch; James Mattis (show all 11); Ian Gibbons; John Carreyrou; George P. Shultz; Channing Robertson; Henry Kissinger
- Important places
- Silicon Valley, California, USA
- Important events
- Collapse of Theranos (2018)
- Related movies
- Bad Blood (IMDb)
- Dedication
- For Molly, Sebastian, Jack, and Francesca
- First words
- Tim Kemp had good news for his team.
- Last words
- (Click to show. Warning: May contain spoilers.)If there was collateral damage on her way to riches and fame, so be it.
- Blurbers
- Gates, Bill
- Original language
- English US
- Canonical DDC/MDS
- 338.7681761
- Canonical LCC
- HD9995.H423
*Some information comes from Common Knowledge in other languages. Click "Edit" for more information.
Classifications
- Genres
- Business, General Nonfiction, Technology, Nonfiction, Science & Nature, History
- DDC/MDS
- 338.7681761 — Society, government, & culture Economics Production Business Enterprises By Industry Manufacture of products for specific uses
- LCC
- HD9995 .H423 — Social sciences Industries. Land use. Labor Industries. Land use. Labor Special industries and trades
- BISAC
Statistics
- Members
- 3,382
- Popularity
- 4,984
- Reviews
- 208
- Rating
- (4.30)
- Languages
- 9 — Dutch, English, French, German, Italian, Polish, Portuguese, Swedish, Chinese, traditional
- Media
- Paper, Audiobook, Ebook
- ISBNs
- 36
- ASINs
- 12



























































